hit counter

Antidepressant Augmentation Strategies for Treatment-Resistant Depression

Antidepressant augmentation strategies are commonly reviewed when an individual is unresponsive to monotherapeutic treatment. In other words, people that try treatments by themselves such as: using an SSRI medication or going to cognitive behavioral therapy (CBT) may not have as great of a response as if the treatments were combined. In some cases, a person …

Read more

Lanicemine (AZD6765) For Treatment-Resistant Depression: NMDA Antagonist

Lanicemine (AZD6765) is an NMDA antagonist developed by the company AstraZeneca in hopes to help people with treatment-resistant depression. Let’s face it, if you have treatment-resistant depression, you are probably waiting for some sort of breakthrough in technology and/or a new class of drugs for treatment. Although many people find benefit from SSRI’s, TCA’s, and …

Read more